GC62384
Epitinib succinate
Also known as butanedioic acid;4-ethyl-N-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide
Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration· Epitinib succinate can be used for the research of cancer
ChemicalCAS2252334-12-4MW548.59FormulaC28H32N6O6
- CAS number
- 2252334-12-4
- Molecular weight
- 548.59
- Formula
- C28H32N6O6
- InChIKey
- HISXHQFAOANCJX-UHFFFAOYSA-N
- Catalogue number
- GC62384
- Brand
- GLPBIO
Computed properties PubChem CID 135379897 · TPSA 157 Ų · H-bond donors 4 · H-bond acceptors 10
- TPSA
- 157 Ų
- H-bond donors
- 4
- H-bond acceptors
- 10
- Rotatable bonds
- 9
- Heavy atoms
- 40
SMILES CCN1CCN(CC1)C(=O)NC2=C(C=C3C(=C2)C(=NC=N3)NC4=CC=CC(=C4)C#C)OC.C(CC(=O)O)C(=O)O
Computed descriptors from PubChem (CID 135379897), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il